Stocks Explorer
Stocks
Sectors
Search
CAPRICOR THERAP. DL-001(4LN2) News
Profile
Chart
News
Analysis
4LN2 price today
by TradingView
Date
Title
Jan 3
CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA
Jan 2
Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
‹ Prev
Page
of 1
Next ›